MOMA Therapeutics
12 known investors
A drug discovery company staffed by scientists and industry specialists focused on developing pharmaceutical candidates.
Founders & leadership
Investors · 12
Nextech InvestZurich · $648K – $3.2M
Third Rock VenturesBoston · $100K – $5M
AlexandriareportedPasadena
Casdin CapitalreportedNew York
Creacion VenturesreportedGrand Cayman
Goldman Sachsreported · 2 sourcesNew York
InvusreportedNew York
LifeSci Venture PartnersreportedNew York
Rock Springs CapitalreportedBaltimore
Section 32reportedPalo Alto
Also in the syndicate · 2
Cormorant Asset ManagementPavilion Capital
Funding
SEC filings, press & company announcements$150M disclosed across 1 round · 2022
- $150Mseries BMay 2022 · 3 sources
Goldman Sachs Asset Management (lead), Cormorant Asset Management, Invus, LifeSci Venture Partners, Nextech Invest, Pavilion Capital, Section 32, Third Rock Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through MOMA Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- What does MOMA Therapeutics do?
- A drug discovery company staffed by scientists and industry specialists focused on developing pharmaceutical candidates.
- Who founded MOMA Therapeutics?
- MOMA Therapeutics was founded by Timur Yusufzai.
- Who are MOMA Therapeutics's investors?
- MOMA Therapeutics's investors include Nextech Invest, Third Rock Ventures, Alexandria, Casdin Capital, Creacion Ventures, Goldman Sachs, Invus, LifeSci Venture Partners and 2 more.
- How much funding has MOMA Therapeutics raised?
- MOMA Therapeutics has disclosed $150M raised across 1 round.